Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma
Author:
Affiliation:
1. Division of Hematology/Oncology, Department of Medicine; Kameda Medical Center; Chiba; Japan
2. Department of Epidemiology; Aichi Cancer Center; Nagoya; Japan
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12050/fullpdf
Reference31 articles.
1. Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials;Harousseau;J Clin Oncol,2009
2. Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial;Moreau;Blood,2011
3. Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients;Gay;Blood,2011
4. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results;Hughes;Blood,2006
5. Minimal residual disease in acute lymphoblastic leukemia;Campana;Hematology Am Soc Hematol Educ Program,2010
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The implication of serum HLA-G in angiogenesis of multiple myeloma;Molecular Medicine;2024-06-14
2. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy;American Journal of Clinical Pathology;2023-11-04
3. The Society of Laboratory Diagnostics Working Grouprecommendations for serum protein electrophoresis. 2023;Diagnostyka Laboratoryjna;2023-09-29
4. The role of serum-free light chain ratios in the prediction of poor prognosis in multiple myeloma patients: a systematic review and meta-analysis;Hematology;2022-09-27
5. Prognostic value of serum free light chain at diagnosis of multiple myeloma;Medical Science;2022-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3